HCA · HCA Healthcare, Inc.
$426.94
+1.36% last session
End-of-day data · close of 2026-09-11
Market cap
$93B
Enterprise value
$145B
Trailing P/E
14.1
Forward P/E
13.1
Dividend yield
1.0%
Beta
1.11
Avg volume
2M
Employees
230K
Daily Change %
1.36%
5 Days Change
4.16%
10 Days Change
1.78%
30 Days Change
2.53%
60 Days Change
3.75%
Month to Day Change
1.99%
Year to Day Change
-9.33%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — HCA
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-09-08
Latest call per bank · past 12 months
RBC Capital
Outperform$435
+3.3% vs priceJP Morgan
Neutral$425
+0.9% vs priceWells Fargo
Equal-Weight$381
-9.5% vs priceGoldman Sachs
Buy$485
+15.1% vs priceUBS
Buy$579
+37.5% vs priceMorgan Stanley
Underweight$380
-9.8% vs priceBarclays
Equal-Weight$387
-8.1% vs priceJefferies
Buy$590
+40.1% vs priceDeutsche Bank
Buy$558
+32.5% vs priceBank of America
Neutral$470
+11.6% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-08 | RBC Capital | Reiterates | Outperform | $435 |
| 2026-08-20 | JP Morgan | Maintains | Neutral | $490 → $425 |
| 2026-08-03 | Wells Fargo | Maintains | Equal-Weight | $369 → $381 |
| 2026-07-28 | Goldman Sachs | Maintains | Buy | $558 → $485 |
| 2026-07-28 | Mizuho | Maintains | Outperform | $525 → $475 |
| 2026-07-27 | UBS | Maintains | Buy | $635 → $579 |
| 2026-07-27 | Morgan Stanley | Maintains | Underweight | $425 → $380 |
| 2026-07-27 | RBC Capital | Reiterates | Outperform | $435 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 60 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 5.4% above the 50-day MA ($404.98).
- Price vs 200-day MA: Trading 5.1% below the 200-day MA ($449.74).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is positive (+0.08) — short-term momentum is improving.
- 52-week range: Price sits between the 52-week low ($360.60) and high ($543.23).
HCA Price Chart
Loading chart for HCA…
Fundamentals
About HCA Healthcare, Inc.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
More in Medical Care Facilities
THC
Tenet Healthcare Corporation
$21B 35.4% YTD
FMS
Fresenius Medical Care AG
$12B -2.5% YTD
EHC
Encompass Health Corporation
$12B 15.1% YTD
DVA
DaVita Inc.
$12B 61.1% YTD
UHS
Universal Health Services, Inc.
$10B -19.1% YTD
ENSG
The Ensign Group, Inc.
$10B -1.3% YTD
CHE
Chemed Corp
$7B 21.7% YTD
PACS
PACS Group, Inc.
$7B 16.2% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.